Fibrin microthreads
US-9662415-B2 · May 30, 2017 · US
US10322206B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10322206-B2 |
| Application number | US-201715472330-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 29, 2017 |
| Priority date | Mar 29, 2016 |
| Publication date | Jun 18, 2019 |
| Grant date | Jun 18, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates, in part, to sutures which promote wound closure and/or healing. In particular, the present invention provides fibrin microthread sutures that mimic the mechanical behavior of a target tissue thereby reducing, for example, scarring, inflammation, and cell death at the ligature site, including monofilament sutures.
Opening claim text (preview).
What is claimed is: 1. A method for promoting wound closure and/or healing of a target tissue in a subject, comprising applying a monofilament suture to the target tissue, wherein the monofilament is: a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution. 2. The method of claim 1 , wherein the suture exhibits a stiffness of about 5 MPa to about 20 MPa as measured by Young's modulus. 3. The method of claim 1 , wherein the suture is associated with one or more of a substrate or a physiologically acceptable patch, a dressing, a bandage, or a natural or mechanical valve. 4. The method of claim 1 , wherein the target tissue is a soft tissue selected from skin, tendon, ligament, fascia, fibrous tissue, fat, synovial membrane, and muscle, nerve and blood vessel. 5. The method of claim 4 , wherein the soft tissue is skin. 6. The method of claim 1 , wherein the target tissue is hypertrophic or swollen. 7. The method of claim 1 , wherein the wound is a surgical wound. 8. The method of claim 7 , wherein the surgical wound results from aesthetic surgery. 9. The method of claim 7 , wherein the surgical wound results from skin grafting. 10. The method of claim 1 , wherein the wound is a trauma wound. 11. A method for promoting wound closure and/or healing of a target tissue, comprising applying a monofilament suture to the target tissue of a subject, wherein the monofilament is a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution, and wherein the subject has not received a standard of care suture. 12. The method of claim 11 , wherein the standard of care suture comprises silk, linen, nylon, polypropylene, polyamide, polyester, catgut, polyglycolic acid, polyglactin 910, poliglecaprone, or polydioxanone. 13. A method for promoting wound closure and/or healing of a target tissue, comprising applying a monofilament suture to the target tissue of a subject, wherein the monofilament is a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution, and wherein the subject has not received an adjuvant therapy. 14. The method of claim 13 , wherein the adjuvant therapy is selected from steroid, silicone, vitamin, laser treatment, radiotherapy, pressure dressing, collagen induction therapy, cryotherapy, or dermabrasion. 15. The method of claim 1 , wherein the monofilament suture is not a multifilament fibrin microthread.
Related publications grouped by family.
Answers are generated from the same data shown on this page.